LUMOS PHARMA, INC. Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LUMOS PHARMA, INC. for January 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 10.55 | 326,288 | 3,442,338 | 326,288 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 11.04 | 3,169 | 34,986 | 274,322 | 277.5 K to 274.3 K (-1.14 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 10.28 | 5,265 | 54,124 | 277,491 | 282.8 K to 277.5 K (-1.86 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Option Exercise | A | 10.55 | 75,000 | 791,250 | 75,000 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 11.04 | 603 | 6,657 | 19,271 | 19.9 K to 19.3 K (-3.03 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 10.28 | 1,237 | 12,716 | 19,874 | 21.1 K to 19.9 K (-5.86 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Option Exercise | A | 10.55 | 137,500 | 1,450,625 | 137,500 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 11.04 | 1,323 | 14,606 | 58,612 | 59.9 K to 58.6 K (-2.21 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 10.28 | 164 | 1,686 | 59,935 | 60.1 K to 59.9 K (-0.27 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Option Exercise | A | 10.55 | 37,500 | 395,625 | 37,500 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Payment of Exercise | F | 11.04 | 257 | 2,837 | 9,551 | 9.8 K to 9.6 K (-2.62 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Payment of Exercise | F | 10.28 | 883 | 9,077 | 9,808 | 10.7 K to 9.8 K (-8.26 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | A | 10.55 | 312,500 | 3,296,875 | 312,500 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 11.04 | 2,085 | 23,018 | 59,933 | 62 K to 59.9 K (-3.36 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 10.28 | 3,266 | 33,574 | 62,018 | 65.3 K to 62 K (-5.00 %) |